Cross-resistance analysis and molecular modeling of nonnucleoside reverse transcriptase inhibitors targeting drug-resistance mutations in the reverse transcriptase of human immunodeficiency virus

Leukemia

Volumn 11, Issue SUPPL. 3, 1997, Pages 89-92

  Yang, Stringner Sue ^a  

^a Antiviral Evaluations Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; OXATHIIN DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

CELL CULTURE; CONFERENCE PAPER; CROSS RESISTANCE; DRUG COMBINATION; DRUG DESIGN; DRUG RESISTANCE; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0030860860     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Yang S.S. et al. Characteristics of a group of nonnudeoslde reverse transcrlptase Inhibitors with structural diversity and potent anti-human Immunodeficiency virus activity. Leukemia 1995: U:S75-S85.
2. Meltors J.W. el I. Mutations In H1V-1 reverse transcrlptase and protease associated with drug resistance. International Antiviral News 1995:3:8-13.